SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178879-19-000008
Filing Date
2019-01-24
Accepted
2019-01-24 09:13:54
Documents
13
Period of Report
2019-01-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K january242019form8-k.htm 8-K 25641
2 EXHIBIT 10.1 exhibit1012.htm EX-10.1 31630
3 amicuslogoa03.jpg GRAPHIC 127191
4 exhibit1012001.jpg GRAPHIC 290800
5 exhibit1012002.jpg GRAPHIC 293066
6 exhibit1012003.jpg GRAPHIC 317098
7 exhibit1012004.jpg GRAPHIC 278584
8 exhibit1012005.jpg GRAPHIC 267188
9 exhibit1012006.jpg GRAPHIC 263668
10 exhibit1012007.jpg GRAPHIC 195227
11 exhibit1012008.jpg GRAPHIC 27651
12 exhibit1012009.jpg GRAPHIC 22350
13 exhibit1012010.jpg GRAPHIC 53656
  Complete submission text file 0001178879-19-000008.txt   2993938
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 19538722
SIC: 2834 Pharmaceutical Preparations